SpaceX $2T IPO filing drives RKLB +11% surge
Key Questions
What triggered the recent 11% surge in Rocket Lab (RKLB) stock?
SpaceX's $2T IPO filing sparked the surge, driving RKLB up 11% to around $68 with a $38B market cap. This was reinforced by bullish analyst coverage and sector momentum.
What was the Citizens analyst upgrade for RKLB?
Citizens analyst Trevor J. Walsh upgraded RKLB from Market Perform to Outperform (Buy equivalent) with an $85 price target, citing defense and Space Force opportunities worth $88.5B as catalysts alongside SpaceX developments.
How did RKLB stock perform in the latest session?
RKLB closed at $66.32, down 1.9-2% amid a market uptick, but held better than the sector's -10% monthly decline. After-hours trading saw a +5.2% rise to $69.75.
What options activity was reported for Rocket Lab?
On April 7th, 78,091 contracts were traded with 825.32K open interest, indicating strong bullish flow with 78k call contracts at 62%.
What is Rocket Lab's Q1 revenue estimate?
Q1 revenue is estimated at $191M, up 56% year-over-year. This aligns with ongoing sector re-rating and positive May expectations.
$2T SpaceX IPO filing sparks RKLB +11% to ~$68/$38B mcap; Barron's/Citizens Walsh Outperform $85 upgrade (+25% upside) cites defense/Space Force $88.5B/SpaceX catalyst, reinforced by Intellectia coverage and bullish options flow (78k contracts calls 62%). Now $66.32 -2% close (AH +5.2% $69.75) holding vs sector -10% mo, Q1 rev $191M +56% May; sector re-rating/UFO ETF context.